ID   PDE4A_HUMAN             Reviewed;         886 AA.
AC   P27815; O75522; O76092; Q16255; Q16691; Q5DM53; Q6PMT2; Q8IVA7;
AC   Q8WUQ3; Q9H3H2;
DT   01-AUG-1992, integrated into UniProtKB/Swiss-Prot.
DT   17-OCT-2006, sequence version 3.
DT   10-MAY-2017, entry version 166.
DE   RecName: Full=cAMP-specific 3',5'-cyclic phosphodiesterase 4A;
DE            EC=3.1.4.53;
DE   AltName: Full=DPDE2;
DE   AltName: Full=PDE46;
GN   Name=PDE4A; Synonyms=DPDE2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=8413254; DOI=10.1128/MCB.13.10.6558;
RA   Bolger G., Michaeli T., Martins T., St John T., Steiner B.,
RA   Rodgers L., Riggs M., Wigler M., Ferguson K.;
RT   "A family of human phosphodiesterases homologous to the dunce learning
RT   and memory gene product of Drosophila melanogaster are potential
RT   targets for antidepressant drugs.";
RL   Mol. Cell. Biol. 13:6558-6571(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3).
RX   PubMed=7888306; DOI=10.1016/0898-6568(94)00039-5;
RA   Sullivan M., Egerton M., Shakur Y., Marquardsen A., Houslay M.D.;
RT   "Molecular cloning and expression, in both COS-1 cells and S.
RT   cerevisiae, of a human cytosolic type-IVA, cyclic AMP specific
RT   phosphodiesterase (hPDE-IVA-h6.1).";
RL   Cell. Signal. 6:793-812(1994).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 3 AND 5), AND VARIANT GLU-736.
RX   PubMed=7772058; DOI=10.1042/bj3080683;
RA   Horton Y.M., Sullivan M., Houslay M.D.;
RT   "Molecular cloning of a novel splice variant of human type IVA (PDE-
RT   IVA) cyclic AMP phosphodiesterase and localization of the gene to the
RT   p13.2-q12 region of human chromosome 19.";
RL   Biochem. J. 308:683-691(1995).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORMS 1; 2; 3; 4 AND 5).
RC   TISSUE=Brain;
RX   PubMed=9677330; DOI=10.1042/bj3330693;
RA   Sullivan M., Rena G., Begg F., Gordon L., Olsen A.S., Houslay M.D.;
RT   "Identification and characterization of the human homologue of the
RT   short PDE4A cAMP-specific phosphodiesterase 4A variant RD1 (PDE4A1) by
RT   analysis of the human HSPDE4A gene locus located at chromosome
RT   19p13.2.";
RL   Biochem. J. 333:693-703(1998).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 6), SUBCELLULAR LOCATION,
RP   BIOPHYSICOCHEMICAL PROPERTIES, ENZYME REGULATION, TISSUE SPECIFICITY,
RP   AND INTERACTION WITH LYN.
RC   TISSUE=Brain;
RX   PubMed=11306681;
RA   Rena G., Begg F., Ross A., MacKenzie C., McPhee I., Campbell L.,
RA   Huston E., Sullivan M., Houslay M.D.;
RT   "Molecular cloning, genomic positioning, promoter identification, and
RT   characterization of the novel cyclic AMP-specific phosphodiesterase
RT   PDE4A10.";
RL   Mol. Pharmacol. 59:996-1011(2001).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), SUBCELLULAR LOCATION, TISSUE
RP   SPECIFICITY, ENZYME REGULATION, BIOPHYSICOCHEMICAL PROPERTIES,
RP   PHOSPHORYLATION AT SER-119 (ISOFORM 2), CLEAVAGE BY CASPASE-3 (ISOFORM
RP   1), AND INTERACTION WITH LYN AND ARRB2.
RX   PubMed=15738310; DOI=10.1124/mol.104.009423;
RA   Wallace D.A., Johnston L.A., Huston E., Macmaster D., Houslay T.M.,
RA   Cheung Y.-F., Campbell L., Millen J.E., Smith R.A., Gall I.,
RA   Knowles R.G., Sullivan M., Houslay M.D.;
RT   "Identification and characterization of PDE4A11, a novel, widely
RT   expressed long isoform encoded by the human PDE4A cAMP
RT   phosphodiesterase gene.";
RL   Mol. Pharmacol. 67:1920-1934(2005).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 7), SUBCELLULAR LOCATION, ENZYME
RP   REGULATION, TISSUE SPECIFICITY, AND PHOSPHORYLATION AT SER-123
RP   (ISOFORM 7).
RX   PubMed=18095939; DOI=10.1042/BJ20071251;
RA   Mackenzie K.F., Topping E.C., Bugaj-Gaweda B., Deng C., Cheung Y.-F.,
RA   Olsen A.E., Stockard C.R., High Mitchell L., Baillie G.S.,
RA   Grizzle W.E., De Vivo M., Houslay M.D., Wang D., Bolger G.B.;
RT   "Human PDE4A8, a novel brain-expressed PDE4 cAMP-specific
RT   phosphodiesterase that has undergone rapid evolutionary change.";
RL   Biochem. J. 411:361-369(2008).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J.,
RA   Lamerdin J.E., Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M.,
RA   Aerts A., Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E.,
RA   Caenepeel S., Carrano A.V., Caoile C., Chan Y.M., Christensen M.,
RA   Cleland C.A., Copeland A., Dalin E., Dehal P., Denys M., Detter J.C.,
RA   Escobar J., Flowers D., Fotopulos D., Garcia C., Georgescu A.M.,
RA   Glavina T., Gomez M., Gonzales E., Groza M., Hammon N., Hawkins T.,
RA   Haydu L., Ho I., Huang W., Israni S., Jett J., Kadner K., Kimball H.,
RA   Kobayashi A., Larionov V., Leem S.-H., Lopez F., Lou Y., Lowry S.,
RA   Malfatti S., Martinez D., McCready P.M., Medina C., Morgan J.,
RA   Nelson K., Nolan M., Ovcharenko I., Pitluck S., Pollard M.,
RA   Popkie A.P., Predki P., Quan G., Ramirez L., Rash S., Retterer J.,
RA   Rodriguez A., Rogers S., Salamov A., Salazar A., She X., Smith D.,
RA   Slezak T., Solovyev V., Thayer N., Tice H., Tsai M., Ustaszewska A.,
RA   Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J., Dubchak I.,
RA   Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 112-886, AND VARIANT GLU-736.
RC   TISSUE=Monocyte;
RX   PubMed=2160582; DOI=10.1128/MCB.10.6.2678;
RA   Livi G.P., Kmetz P., McHale M.M., Cieslinski L.B., Sathe G.M.,
RA   Taylor D.P., Davis R.L., Torphy T.J., Balcarek J.M.;
RT   "Cloning and expression of cDNA for a human low-Km, rolipram-sensitive
RT   cyclic AMP phosphodiesterase.";
RL   Mol. Cell. Biol. 10:2678-2686(1990).
RN   [12]
RP   SEQUENCE REVISION.
RA   McLaughlin M.M.;
RL   Submitted (JAN-1991) to the EMBL/GenBank/DDBJ databases.
RN   [13]
RP   FUNCTION, PHOSPHORYLATION AT SER-686 AND SER-688, PHOSPHORYLATION AT
RP   SER-119 (ISOFORM 2), PHOSPHORYLATION AT SER-123 (ISOFORM 7), AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=11566027; DOI=10.1006/abbi.2001.2513;
RA   Lario P.I., Bobechko B., Bateman K., Kelly J., Vrielink A., Huang Z.;
RT   "Purification and characterization of the human pde4a catalytic domain
RT   (pde4a(330-723)) expressed in sf9 cells.";
RL   Arch. Biochem. Biophys. 394:54-60(2001).
RN   [14]
RP   SPLICE ISOFORM(S) THAT ARE POTENTIAL NMD TARGET(S).
RX   PubMed=14759258; DOI=10.1186/gb-2004-5-2-r8;
RA   Hillman R.T., Green R.E., Brenner S.E.;
RT   "An unappreciated role for RNA surveillance.";
RL   Genome Biol. 5:R8.1-R8.16(2004).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-165, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [17]
RP   SUMOYLATION AT LYS-358 BY PIAS4.
RX   PubMed=20196770; DOI=10.1042/BJ20091672;
RA   Li X., Vadrevu S., Dunlop A., Day J., Advant N., Troeger J.,
RA   Klussmann E., Jaffrey E., Hay R.T., Adams D.R., Houslay M.D.,
RA   Baillie G.S.;
RT   "Selective SUMO modification of cAMP-specific phosphodiesterase-4D5
RT   (PDE4D5) regulates the functional consequences of phosphorylation by
RT   PKA and ERK.";
RL   Biochem. J. 428:55-65(2010).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-13; SER-209 AND SER-346,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [19]
RP   X-RAY CRYSTALLOGRAPHY (2.10 ANGSTROMS) OF 351-683 IN COMPLEX WITH
RP   METAL IONS AND THE INHIBITOR NVP, FUNCTION, AND COFACTOR.
RX   PubMed=17727341; DOI=10.1042/BJ20070970;
RA   Wang H., Peng M.-S., Chen Y., Geng J., Robinson H., Houslay M.D.,
RA   Cai J., Ke H.;
RT   "Structures of the four subfamilies of phosphodiesterase-4 provide
RT   insight into the selectivity of their inhibitors.";
RL   Biochem. J. 408:193-201(2007).
RN   [20]
RP   X-RAY CRYSTALLOGRAPHY (2.25 ANGSTROMS) OF 351-683 IN COMPLEX WITH
RP   METAL IONS AND INHIBITOR.
RA   Cheng R.K.Y., Crawley L., Barker J., Wood M., Felicetti B.,
RA   Whittaker M.;
RT   "Crystal structure of human PDE4a with 4-(3-butoxy-4-
RT   methoxyphenyl)methyl-2-imidazolidone.";
RL   Submitted (JUL-2009) to the PDB data bank.
CC   -!- FUNCTION: Hydrolyzes the second messenger cAMP, which is a key
CC       regulator of many important physiological processes.
CC       {ECO:0000269|PubMed:11566027, ECO:0000269|PubMed:17727341}.
CC   -!- CATALYTIC ACTIVITY: Adenosine 3',5'-cyclic phosphate + H(2)O =
CC       adenosine 5'-phosphate.
CC   -!- COFACTOR:
CC       Name=a divalent metal cation; Xref=ChEBI:CHEBI:60240;
CC         Evidence={ECO:0000269|PubMed:17727341};
CC       Note=Binds 2 divalent metal cations per subunit. Site 1 may
CC       preferentially bind zinc ions, while site 2 has a preference for
CC       magnesium and/or manganese ions. {ECO:0000269|PubMed:17727341};
CC   -!- ENZYME REGULATION: Isoform 1, isoform 2, isoform 6 and isoform 7
CC       are inhibited by rolipram and cilomilast. Isoform 1, isoform 2 and
CC       isoform 6 are inhibited by 4-[(3-butoxy-4-methoxyphenyl)-methyl]-
CC       2-imidazolidinone (Ro 20-1724), roflumilast and denbufylline.
CC       {ECO:0000269|PubMed:11306681, ECO:0000269|PubMed:15738310,
CC       ECO:0000269|PubMed:18095939}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=4.0 uM for cAMP (isoform 2) {ECO:0000269|PubMed:11306681,
CC         ECO:0000269|PubMed:15738310};
CC         KM=3 uM for cAMP (isoform 6) {ECO:0000269|PubMed:11306681,
CC         ECO:0000269|PubMed:15738310};
CC   -!- PATHWAY: Purine metabolism; 3',5'-cyclic AMP degradation; AMP from
CC       3',5'-cyclic AMP: step 1/1.
CC   -!- SUBUNIT: Isoform 1 interacts with LYN. Isoform 2 and isoform 6
CC       interact weakly with LYN. Isoform 1, isoform 2 and isoform 6
CC       interact with ARRB2. {ECO:0000269|PubMed:11306681,
CC       ECO:0000269|PubMed:15738310, ECO:0000269|PubMed:17727341,
CC       ECO:0000269|Ref.20}.
CC   -!- SUBCELLULAR LOCATION: Isoform 1: Cytoplasm, perinuclear region.
CC   -!- SUBCELLULAR LOCATION: Isoform 2: Cytoplasm, perinuclear region.
CC       Cell projection, ruffle membrane.
CC   -!- SUBCELLULAR LOCATION: Isoform 4: Membrane; Peripheral membrane
CC       protein. Note=Isoform 4 has propensity for association with
CC       membranes.
CC   -!- SUBCELLULAR LOCATION: Isoform 6: Cytoplasm, perinuclear region.
CC   -!- SUBCELLULAR LOCATION: Isoform 7: Cytoplasm. Membrane.
CC       Note=Predominantly cytoplasmic.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=7;
CC         Comment=Additional isoforms seem to exist.;
CC       Name=1; Synonyms=PDE4A4, PDE4A4B, PDE46;
CC         IsoId=P27815-1; Sequence=Displayed;
CC       Name=2; Synonyms=TM3, PDE4A11;
CC         IsoId=P27815-2; Sequence=VSP_004556;
CC         Note=Contains a phosphoserine at position 119.
CC         {ECO:0000269|PubMed:11566027};
CC       Name=3; Synonyms=PDE4A7, PDE4A6;
CC         IsoId=P27815-3; Sequence=VSP_004557;
CC       Name=4; Synonyms=PDE4A1, RD1;
CC         IsoId=P27815-4; Sequence=VSP_004558;
CC       Name=5; Synonyms=PDE4A8A, 2EL;
CC         IsoId=P27815-5; Sequence=VSP_004559, VSP_004560, VSP_004561;
CC         Note=May be produced at very low levels due to a premature stop
CC         codon in the mRNA, leading to nonsense-mediated mRNA decay.
CC         Probably represents a non-functional splice isoform.;
CC       Name=6; Synonyms=PDE4A10;
CC         IsoId=P27815-6; Sequence=VSP_038185;
CC       Name=7; Synonyms=PDE4A8;
CC         IsoId=P27815-7; Sequence=VSP_038186;
CC         Note=Contains a phosphoserine at position 123.
CC         {ECO:0000269|PubMed:11566027};
CC   -!- TISSUE SPECIFICITY: Isoform 1 is widely expressed. Isoform 2 is
CC       abundant in liver, stomach, testis, thyroid and adrenal glands. It
CC       is also found in placenta, kidney, pancreas, ovary, uterus, skin,
CC       monocytes, mast cells, macrophages, as well as in bronchial smooth
CC       muscle. Isoform 6 is expressed at high levels in the heart and
CC       small intestine. It is also found in the brain, kidney, spleen,
CC       colon, salivary gland, ovary and peripheral blood lymphocytes.
CC       Isoform 7 is expressed predominantly in skeletal muscle and brain
CC       and at lower levels in the testis. Isoform 7 is expressed in the
CC       brain. Found in specific neuronal subpopulations in cortex, spinal
CC       cord and cerebellum (at protein level).
CC       {ECO:0000269|PubMed:11306681, ECO:0000269|PubMed:15738310,
CC       ECO:0000269|PubMed:18095939}.
CC   -!- PTM: Phosphorylation by MAPKAPK2 its activation through PKA
CC       phosphorylation (By similarity). Phosphorylated at Ser-686 and
CC       Ser-688 when expressed in S.frugiperda cells. Isoform 2 and
CC       isoform 7 are activated by phosphorylation at Ser-119 and Ser-123
CC       respectively by PKA. {ECO:0000250, ECO:0000269|PubMed:11566027}.
CC   -!- PTM: Proteolytically cleaved by caspase-3.
CC   -!- SIMILARITY: Belongs to the cyclic nucleotide phosphodiesterase
CC       family. PDE4 subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L20965; AAA03588.1; -; mRNA.
DR   EMBL; S75213; AAB33798.1; -; mRNA.
DR   EMBL; U18087; AAC50458.1; -; mRNA.
DR   EMBL; U18088; AAA98540.1; -; mRNA.
DR   EMBL; AF069491; AAC35012.1; -; Genomic_DNA.
DR   EMBL; AF069487; AAC35012.1; JOINED; Genomic_DNA.
DR   EMBL; AF069489; AAC35012.1; JOINED; Genomic_DNA.
DR   EMBL; AF069490; AAC35012.1; JOINED; Genomic_DNA.
DR   EMBL; AF069491; AAC35013.1; -; Genomic_DNA.
DR   EMBL; AF069489; AAC35013.1; JOINED; Genomic_DNA.
DR   EMBL; AF069490; AAC35013.1; JOINED; Genomic_DNA.
DR   EMBL; AF069491; AAC35014.1; -; Genomic_DNA.
DR   EMBL; AF069489; AAC35014.1; JOINED; Genomic_DNA.
DR   EMBL; AF069490; AAC35014.1; JOINED; Genomic_DNA.
DR   EMBL; AF069491; AAC35015.1; -; Genomic_DNA.
DR   EMBL; AF069488; AAC35015.1; JOINED; Genomic_DNA.
DR   EMBL; AF069489; AAC35015.1; JOINED; Genomic_DNA.
DR   EMBL; AF069490; AAC35015.1; JOINED; Genomic_DNA.
DR   EMBL; U68532; AAC63832.1; -; mRNA.
DR   EMBL; U97584; AAC25679.1; -; mRNA.
DR   EMBL; AF073745; AAD34217.2; -; mRNA.
DR   EMBL; AY618547; AAU82096.1; -; mRNA.
DR   EMBL; AY593872; AAT00628.1; -; mRNA.
DR   EMBL; AC011548; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC011529; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC011461; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471106; EAW84104.1; -; Genomic_DNA.
DR   EMBL; CH471106; EAW84105.1; -; Genomic_DNA.
DR   EMBL; CH471106; EAW84108.1; -; Genomic_DNA.
DR   EMBL; BC019864; AAH19864.1; -; mRNA.
DR   EMBL; BC038234; AAH38234.1; -; mRNA.
DR   EMBL; M37744; AAA69697.1; -; mRNA.
DR   CCDS; CCDS12238.1; -. [P27815-4]
DR   CCDS; CCDS45961.1; -. [P27815-1]
DR   CCDS; CCDS45962.1; -. [P27815-2]
DR   CCDS; CCDS45963.1; -. [P27815-6]
DR   CCDS; CCDS58649.1; -. [P27815-7]
DR   PIR; A54442; A54442.
DR   PIR; S55348; S55348.
DR   RefSeq; NP_001104777.1; NM_001111307.1. [P27815-1]
DR   RefSeq; NP_001104778.1; NM_001111308.1. [P27815-2]
DR   RefSeq; NP_001104779.1; NM_001111309.1. [P27815-6]
DR   RefSeq; NP_001230050.1; NM_001243121.1. [P27815-7]
DR   RefSeq; NP_006193.1; NM_006202.2. [P27815-4]
DR   RefSeq; XP_011526356.1; XM_011528054.1. [P27815-7]
DR   UniGene; Hs.89901; -.
DR   PDB; 2QYK; X-ray; 2.10 A; A/B=351-683.
DR   PDB; 3I8V; X-ray; 2.25 A; A/B=351-683.
DR   PDB; 3TVX; X-ray; 2.84 A; A/B=351-683.
DR   PDBsum; 2QYK; -.
DR   PDBsum; 3I8V; -.
DR   PDBsum; 3TVX; -.
DR   ProteinModelPortal; P27815; -.
DR   SMR; P27815; -.
DR   BioGrid; 111167; 7.
DR   IntAct; P27815; 4.
DR   STRING; 9606.ENSP00000270474; -.
DR   BindingDB; P27815; -.
DR   ChEMBL; CHEMBL254; -.
DR   DrugBank; DB06842; (4R)-4-(3-butoxy-4-methoxybenzyl)imidazolidin-2-one.
DR   DrugBank; DB05676; Apremilast.
DR   DrugBank; DB00201; Caffeine.
DR   DrugBank; DB05219; Crisaborole.
DR   DrugBank; DB00975; Dipyridamole.
DR   DrugBank; DB06751; Drotaverine.
DR   DrugBank; DB00651; Dyphylline.
DR   DrugBank; DB00824; Enprofylline.
DR   DrugBank; DB05266; Ibudilast.
DR   DrugBank; DB01088; Iloprost.
DR   DrugBank; DB00920; Ketotifen.
DR   DrugBank; DB01303; Oxtriphylline.
DR   DrugBank; DB05876; PDE4.
DR   DrugBank; DB00806; Pentoxifylline.
DR   DrugBank; DB01791; Piclamilast.
DR   DrugBank; DB01656; Roflumilast.
DR   DrugBank; DB00277; Theophylline.
DR   DrugBank; DB08811; Tofisopam.
DR   GuidetoPHARMACOLOGY; 1300; -.
DR   iPTMnet; P27815; -.
DR   PhosphoSitePlus; P27815; -.
DR   BioMuta; PDE4A; -.
DR   DMDM; 116242706; -.
DR   EPD; P27815; -.
DR   MaxQB; P27815; -.
DR   PaxDb; P27815; -.
DR   PeptideAtlas; P27815; -.
DR   PRIDE; P27815; -.
DR   DNASU; 5141; -.
DR   Ensembl; ENST00000293683; ENSP00000293683; ENSG00000065989. [P27815-2]
DR   Ensembl; ENST00000344979; ENSP00000341007; ENSG00000065989. [P27815-4]
DR   Ensembl; ENST00000380702; ENSP00000370078; ENSG00000065989. [P27815-1]
DR   Ensembl; ENST00000440014; ENSP00000394754; ENSG00000065989. [P27815-6]
DR   Ensembl; ENST00000592685; ENSP00000468507; ENSG00000065989. [P27815-7]
DR   GeneID; 5141; -.
DR   KEGG; hsa:5141; -.
DR   UCSC; uc002moj.3; human. [P27815-1]
DR   CTD; 5141; -.
DR   DisGeNET; 5141; -.
DR   GeneCards; PDE4A; -.
DR   HGNC; HGNC:8780; PDE4A.
DR   HPA; CAB017632; -.
DR   HPA; HPA043310; -.
DR   HPA; HPA076091; -.
DR   MIM; 600126; gene.
DR   neXtProt; NX_P27815; -.
DR   OpenTargets; ENSG00000065989; -.
DR   PharmGKB; PA33128; -.
DR   eggNOG; KOG3689; Eukaryota.
DR   eggNOG; ENOG410XRI7; LUCA.
DR   GeneTree; ENSGT00760000118889; -.
DR   HOVERGEN; HBG108239; -.
DR   KO; K13293; -.
DR   OMA; PSPTMKD; -.
DR   OrthoDB; EOG091G06CD; -.
DR   PhylomeDB; P27815; -.
DR   TreeFam; TF314638; -.
DR   BRENDA; 3.1.4.17; 2681.
DR   BRENDA; 3.1.4.53; 2681.
DR   Reactome; R-HSA-180024; DARPP-32 events.
DR   Reactome; R-HSA-418555; G alpha (s) signalling events.
DR   UniPathway; UPA00762; UER00747.
DR   ChiTaRS; PDE4A; human.
DR   EvolutionaryTrace; P27815; -.
DR   GeneWiki; PDE4A; -.
DR   GenomeRNAi; 5141; -.
DR   PRO; PR:P27815; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; ENSG00000065989; -.
DR   CleanEx; HS_PDE4A; -.
DR   ExpressionAtlas; P27815; baseline and differential.
DR   Genevisible; P27815; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0016020; C:membrane; TAS:ProtInc.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   GO; GO:0032587; C:ruffle membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0004115; F:3',5'-cyclic-AMP phosphodiesterase activity; IDA:BHF-UCL.
DR   GO; GO:0030552; F:cAMP binding; IGI:BHF-UCL.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0006198; P:cAMP catabolic process; IDA:BHF-UCL.
DR   GO; GO:0035690; P:cellular response to drug; IEA:Ensembl.
DR   GO; GO:0043949; P:regulation of cAMP-mediated signaling; IEA:Ensembl.
DR   GO; GO:0010738; P:regulation of protein kinase A signaling; IEA:Ensembl.
DR   GO; GO:0007608; P:sensory perception of smell; IEA:Ensembl.
DR   GO; GO:0007165; P:signal transduction; TAS:ProtInc.
DR   Gene3D; 1.10.1300.10; -; 1.
DR   InterPro; IPR003607; HD/PDEase_dom.
DR   InterPro; IPR023088; PDEase.
DR   InterPro; IPR002073; PDEase_catalytic_dom.
DR   InterPro; IPR023174; PDEase_CS.
DR   Pfam; PF00233; PDEase_I; 1.
DR   PRINTS; PR00387; PDIESTERASE1.
DR   SMART; SM00471; HDc; 1.
DR   PROSITE; PS00126; PDEASE_I; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; cAMP; Cell membrane;
KW   Cell projection; Complete proteome; Cytoplasm; Hydrolase;
KW   Isopeptide bond; Membrane; Metal-binding; Phosphoprotein;
KW   Polymorphism; Reference proteome; Ubl conjugation.
FT   CHAIN         1    886       cAMP-specific 3',5'-cyclic
FT                                phosphodiesterase 4A.
FT                                /FTId=PRO_0000198806.
FT   NP_BIND     433    437       cAMP. {ECO:0000250}.
FT   REGION      330    723       Catalytic.
FT   ACT_SITE    433    433       Proton donor. {ECO:0000250}.
FT   METAL       437    437       Divalent metal cation 1.
FT   METAL       473    473       Divalent metal cation 1.
FT   METAL       474    474       Divalent metal cation 1.
FT   METAL       474    474       Divalent metal cation 2.
FT   METAL       591    591       Divalent metal cation 1.
FT   BINDING     474    474       cAMP. {ECO:0000250}.
FT   BINDING     591    591       cAMP. {ECO:0000250}.
FT   BINDING     642    642       cAMP. {ECO:0000250}.
FT   SITE         69     70       Cleavage; by caspase-3.
FT   SITE        594    594       Binds AMP, but not cAMP. {ECO:0000250}.
FT   MOD_RES      13     13       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     152    152       Phosphoserine; by MAPKAPK2.
FT                                {ECO:0000250}.
FT   MOD_RES     157    157       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P54748}.
FT   MOD_RES     165    165       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332}.
FT   MOD_RES     209    209       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     346    346       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     686    686       Phosphoserine.
FT                                {ECO:0000305|PubMed:11566027}.
FT   MOD_RES     688    688       Phosphoserine.
FT                                {ECO:0000305|PubMed:11566027}.
FT   CROSSLNK    358    358       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO).
FT                                {ECO:0000269|PubMed:20196770}.
FT   VAR_SEQ       1    367       MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPI
FT                                RIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTT
FT                                RMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPL
FT                                DSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRN
FT                                SSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPS
FT                                NKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLE
FT                                TMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYI
FT                                STTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPH
FT                                LQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQ
FT                                -> MVLPSDQGFKLLGNVLQGPEPYRLLTSGLRLHQ (in
FT                                isoform 5). {ECO:0000303|PubMed:7772058,
FT                                ECO:0000303|PubMed:9677330}.
FT                                /FTId=VSP_004559.
FT   VAR_SEQ       1    261       MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPI
FT                                RIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTT
FT                                RMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPL
FT                                DSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRN
FT                                SSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPS
FT                                NKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLE
FT                                TMQTYRSVSEMASHK -> MPLVDFFCETCSKPWLVGWWDQ
FT                                (in isoform 4).
FT                                {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:9677330}.
FT                                /FTId=VSP_004558.
FT   VAR_SEQ       1    209       MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPI
FT                                RIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTT
FT                                RMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPL
FT                                DSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRN
FT                                SSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPS
FT                                NKRS -> MCPFPVTTV (in isoform 3).
FT                                {ECO:0000303|PubMed:7772058,
FT                                ECO:0000303|PubMed:7888306,
FT                                ECO:0000303|PubMed:9677330}.
FT                                /FTId=VSP_004557.
FT   VAR_SEQ       1    107       MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPI
FT                                RIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTT
FT                                RMSWPSSFHGTGTGSGGAGGGSSRR -> MARPRGLGRIPE
FT                                LQLVAFPVAVAAEDEAFLPEPLAPRAPRRPRSPPSSPVFFA
FT                                SPSPTFRRRLRLLRSCQDLGRQAWAGAG (in isoform
FT                                2). {ECO:0000303|PubMed:15738310,
FT                                ECO:0000303|PubMed:9677330}.
FT                                /FTId=VSP_004556.
FT   VAR_SEQ       1    107       MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPI
FT                                RIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTT
FT                                RMSWPSSFHGTGTGSGGAGGGSSRR -> MRSGAAPRARPR
FT                                PPALALPPTGPESLTHFPFSDEDTRRHPPGRSVS (in
FT                                isoform 6).
FT                                {ECO:0000303|PubMed:11306681}.
FT                                /FTId=VSP_038185.
FT   VAR_SEQ       1    107       MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPI
FT                                RIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTT
FT                                RMSWPSSFHGTGTGSGGAGGGSSRR -> MKRSRSALSVAG
FT                                TGDERSRETPESDRANMLGADLRRPRRRLSSGPGLGWAQPE
FT                                PSDPGVPLPPRPTTLPLLIPPRISITRAENDS (in
FT                                isoform 7).
FT                                {ECO:0000303|PubMed:18095939}.
FT                                /FTId=VSP_038186.
FT   VAR_SEQ     644    657       GFIDYIVHPLWETW -> QARGIDGRAQGGFY (in
FT                                isoform 5). {ECO:0000303|PubMed:7772058,
FT                                ECO:0000303|PubMed:9677330}.
FT                                /FTId=VSP_004560.
FT   VAR_SEQ     658    886       Missing (in isoform 5).
FT                                {ECO:0000303|PubMed:7772058,
FT                                ECO:0000303|PubMed:9677330}.
FT                                /FTId=VSP_004561.
FT   VARIANT     736    736       A -> E (in dbSNP:rs1051738).
FT                                {ECO:0000269|PubMed:2160582,
FT                                ECO:0000269|PubMed:7772058}.
FT                                /FTId=VAR_059544.
FT   VARIANT     808    808       H -> Y (in dbSNP:rs2230190).
FT                                /FTId=VAR_059545.
FT   HELIX       362    368       {ECO:0000244|PDB:2QYK}.
FT   HELIX       369    371       {ECO:0000244|PDB:2QYK}.
FT   HELIX       379    385       {ECO:0000244|PDB:2QYK}.
FT   TURN        386    388       {ECO:0000244|PDB:2QYK}.
FT   HELIX       390    401       {ECO:0000244|PDB:2QYK}.
FT   HELIX       404    407       {ECO:0000244|PDB:2QYK}.
FT   HELIX       412    424       {ECO:0000244|PDB:2QYK}.
FT   STRAND      430    434       {ECO:0000244|PDB:2QYK}.
FT   HELIX       435    449       {ECO:0000244|PDB:2QYK}.
FT   HELIX       452    454       {ECO:0000244|PDB:2QYK}.
FT   TURN        455    457       {ECO:0000244|PDB:2QYK}.
FT   HELIX       460    472       {ECO:0000244|PDB:2QYK}.
FT   TURN        473    476       {ECO:0000244|PDB:2QYK}.
FT   HELIX       482    487       {ECO:0000244|PDB:2QYK}.
FT   HELIX       491    495       {ECO:0000244|PDB:2QYK}.
FT   TURN        496    498       {ECO:0000244|PDB:2QYK}.
FT   HELIX       501    512       {ECO:0000244|PDB:2QYK}.
FT   HELIX       513    515       {ECO:0000244|PDB:2QYK}.
FT   TURN        521    524       {ECO:0000244|PDB:2QYK}.
FT   HELIX       527    542       {ECO:0000244|PDB:2QYK}.
FT   HELIX       546    548       {ECO:0000244|PDB:2QYK}.
FT   HELIX       549    561       {ECO:0000244|PDB:2QYK}.
FT   STRAND      567    569       {ECO:0000244|PDB:2QYK}.
FT   HELIX       576    591       {ECO:0000244|PDB:2QYK}.
FT   HELIX       594    596       {ECO:0000244|PDB:2QYK}.
FT   HELIX       599    622       {ECO:0000244|PDB:2QYK}.
FT   TURN        633    635       {ECO:0000244|PDB:2QYK}.
FT   HELIX       638    648       {ECO:0000244|PDB:2QYK}.
FT   HELIX       650    660       {ECO:0000244|PDB:2QYK}.
FT   TURN        661    665       {ECO:0000244|PDB:2QYK}.
FT   HELIX       666    682       {ECO:0000244|PDB:2QYK}.
SQ   SEQUENCE   886 AA;  98143 MW;  92BB9B98BED711E7 CRC64;
     MEPPTVPSER SLSLSLPGPR EGQATLKPPP QHLWRQPRTP IRIQQRGYSD SAERAERERQ
     PHRPIERADA MDTSDRPGLR TTRMSWPSSF HGTGTGSGGA GGGSSRRFEA ENGPTPSPGR
     SPLDSQASPG LVLHAGAATS QRRESFLYRS DSDYDMSPKT MSRNSSVTSE AHAEDLIVTP
     FAQVLASLRS VRSNFSLLTN VPVPSNKRSP LGGPTPVCKA TLSEETCQQL ARETLEELDW
     CLEQLETMQT YRSVSEMASH KFKRMLNREL THLSEMSRSG NQVSEYISTT FLDKQNEVEI
     PSPTMKEREK QQAPRPRPSQ PPPPPVPHLQ PMSQITGLKK LMHSNSLNNS NIPRFGVKTD
     QEELLAQELE NLNKWGLNIF CVSDYAGGRS LTCIMYMIFQ ERDLLKKFRI PVDTMVTYML
     TLEDHYHADV AYHNSLHAAD VLQSTHVLLA TPALDAVFTD LEILAALFAA AIHDVDHPGV
     SNQFLINTNS ELALMYNDES VLENHHLAVG FKLLQEDNCD IFQNLSKRQR QSLRKMVIDM
     VLATDMSKHM TLLADLKTMV ETKKVTSSGV LLLDNYSDRI QVLRNMVHCA DLSNPTKPLE
     LYRQWTDRIM AEFFQQGDRE RERGMEISPM CDKHTASVEK SQVGFIDYIV HPLWETWADL
     VHPDAQEILD TLEDNRDWYY SAIRQSPSPP PEEESRGPGH PPLPDKFQFE LTLEEEEEEE
     ISMAQIPCTA QEALTAQGLS GVEEALDATI AWEASPAQES LEVMAQEASL EAELEAVYLT
     QQAQSTGSAP VAPDEFSSRE EFVVAVSHSS PSALALQSPL LPAWRTLSVS EHAPGLPGLP
     STAAEVEAQR EHQAAKRACS ACAGTFGEDT SALPAPGGGG SGGDPT
//
